List of Tables
Table 1. Global Latanoprost for Chronic Angle Closure Glaucoma Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Latanoprost for Chronic Angle Closure Glaucoma Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Latanoprost for Chronic Angle Closure Glaucoma Market Competitive Situation by Manufacturers in 2025
Table 4. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Latanoprost for Chronic Angle Closure Glaucoma Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Latanoprost for Chronic Angle Closure Glaucoma, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Latanoprost for Chronic Angle Closure Glaucoma, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Latanoprost for Chronic Angle Closure Glaucoma, Product Types and Applications
Table 12. Global Key Manufacturers of Latanoprost for Chronic Angle Closure Glaucoma, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Latanoprost for Chronic Angle Closure Glaucoma Companies by Tier (Tier 1, Tier 2, Tier 3), based on Latanoprost for Chronic Angle Closure Glaucoma Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Latanoprost for Chronic Angle Closure Glaucoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Latanoprost for Chronic Angle Closure Glaucoma Sales by Region (K Units), 2021–2026
Table 18. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Region (2021–2026)
Table 19. Global Latanoprost for Chronic Angle Closure Glaucoma Sales by Region (K Units), 2027–2032
Table 20. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Region (2027–2032)
Table 21. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue by Region (US$ Million), 2021–2026
Table 22. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Region (2021–2026)
Table 23. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue by Region (US$ Million), 2027–2032
Table 24. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Region (2027–2032)
Table 25. North America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2021–2026
Table 27. North America Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2027–2032
Table 28. North America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2021–2026
Table 29. North America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2021–2026
Table 32. Europe Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2027–2032
Table 33. Europe Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2021–2026
Table 42. Latin America Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2027–2032
Table 43. Latin America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Revenue by Country (US$ Million), 2027–2032
Table 50. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units) by Type (2021–2026)
Table 51. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units) by Type (2027–2032)
Table 52. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Type (2021–2026)
Table 53. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Type (2027–2032)
Table 54. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Type (2021–2026)
Table 57. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Type (2027–2032)
Table 58. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Type (2021–2026)
Table 59. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Type (2027–2032)
Table 60. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units) by Application (2021–2026)
Table 61. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units) by Application (2027–2032)
Table 62. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Application (2021–2026)
Table 63. Global Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Application (2027–2032)
Table 64. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Application (2021–2026)
Table 67. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Application (2027–2032)
Table 68. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Application (2021–2026)
Table 69. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Latanoprost for Chronic Angle Closure Glaucoma Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Mylan Latanoprost for Chronic Angle Closure Glaucoma Product
Table 79. Mylan Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Latanoprost for Chronic Angle Closure Glaucoma Product
Table 84. Novartis Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Apotex Latanoprost for Chronic Angle Closure Glaucoma Product
Table 89. Apotex Recent Developments/Updates
Table 90. Teva Company Information
Table 91. Teva Description and Business Overview
Table 92. Teva Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Teva Latanoprost for Chronic Angle Closure Glaucoma Product
Table 94. Teva Recent Developments/Updates
Table 95. Taj Pharma Company Information
Table 96. Taj Pharma Description and Business Overview
Table 97. Taj Pharma Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Taj Pharma Latanoprost for Chronic Angle Closure Glaucoma Product
Table 99. Taj Pharma Recent Developments/Updates
Table 100. CR Zizhu Company Information
Table 101. CR Zizhu Description and Business Overview
Table 102. CR Zizhu Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. CR Zizhu Latanoprost for Chronic Angle Closure Glaucoma Product
Table 104. CR Zizhu Recent Developments/Updates
Table 105. Jiangsu Hengrui Pharmaceuticals Company Information
Table 106. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 107. Jiangsu Hengrui Pharmaceuticals Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Jiangsu Hengrui Pharmaceuticals Latanoprost for Chronic Angle Closure Glaucoma Product
Table 109. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 110. China Medical System Holdings Company Information
Table 111. China Medical System Holdings Description and Business Overview
Table 112. China Medical System Holdings Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. China Medical System Holdings Latanoprost for Chronic Angle Closure Glaucoma Product
Table 114. China Medical System Holdings Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Latanoprost for Chronic Angle Closure Glaucoma Distributors List
Table 118. Latanoprost for Chronic Angle Closure Glaucoma Customers List
Table 119. Latanoprost for Chronic Angle Closure Glaucoma Market Trends
Table 120. Latanoprost for Chronic Angle Closure Glaucoma Market Drivers
Table 121. Latanoprost for Chronic Angle Closure Glaucoma Market Challenges
Table 122. Latanoprost for Chronic Angle Closure Glaucoma Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Latanoprost for Chronic Angle Closure Glaucoma
Figure 2. Global Latanoprost for Chronic Angle Closure Glaucoma Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Latanoprost for Chronic Angle Closure Glaucoma Market Share by Type: 2025 & 2032
Figure 4. Brand Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Latanoprost for Chronic Angle Closure Glaucoma Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Latanoprost for Chronic Angle Closure Glaucoma Market Share by Application: 2025 & 2032
Figure 8. Male Patients
Figure 9. Female Patients
Figure 10. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Latanoprost for Chronic Angle Closure Glaucoma Market Size (US$ Million), 2021–2032
Figure 12. Global Latanoprost for Chronic Angle Closure Glaucoma Sales (K Units), 2021–2032
Figure 13. Global Latanoprost for Chronic Angle Closure Glaucoma Average Price (US$/Unit), 2021–2032
Figure 14. Latanoprost for Chronic Angle Closure Glaucoma Report Years Considered
Figure 15. Latanoprost for Chronic Angle Closure Glaucoma Sales Share by Manufacturers in 2025
Figure 16. Global Latanoprost for Chronic Angle Closure Glaucoma Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Latanoprost for Chronic Angle Closure Glaucoma Players: Market Share by Revenue in Latanoprost for Chronic Angle Closure Glaucoma in 2025
Figure 18. Latanoprost for Chronic Angle Closure Glaucoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Latanoprost for Chronic Angle Closure Glaucoma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Country (2021–2032)
Figure 21. North America Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Country (2021–2032)
Figure 22. United States Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Country (2021–2032)
Figure 25. Europe Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Country (2021–2032)
Figure 26. Germany Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Region (2021–2032)
Figure 33. China Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Country (2021–2032)
Figure 41. Latin America Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Latanoprost for Chronic Angle Closure Glaucoma Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Latanoprost for Chronic Angle Closure Glaucoma Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Latanoprost for Chronic Angle Closure Glaucoma by Type (2021–2032)
Figure 52. Global Revenue Market Share of Latanoprost for Chronic Angle Closure Glaucoma by Type (2021–2032)
Figure 53. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Latanoprost for Chronic Angle Closure Glaucoma by Application (2021–2032)
Figure 55. Global Revenue Market Share of Latanoprost for Chronic Angle Closure Glaucoma by Application (2021–2032)
Figure 56. Global Latanoprost for Chronic Angle Closure Glaucoma Price (US$/Unit) by Application (2021–2032)
Figure 57. Latanoprost for Chronic Angle Closure Glaucoma Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
